Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Shulu Hu"'
Publikováno v:
Discover Oncology, Vol 15, Iss 1, Pp 1-13 (2024)
Abstract Background EphrinA5 belongs to a subclass of ephrin ligands. Abnormal signal transduction of EFNA5 shows a relationship to the development of various tumors. In this study, we explored the level of EFNA5 in hepatoma cells and the influence o
Externí odkaz:
https://doaj.org/article/207d89f224a84a448c5da5a5b5b1b265
Publikováno v:
Preventive Medicine Reports, Vol 42, Iss , Pp 102725- (2024)
Externí odkaz:
https://doaj.org/article/1a779c5e497a4929b9af060ad296b017
Autor:
Yueqin Sun, Weitao Shen, Shulu Hu, Qiong Lyu, Qiongyao Wang, Ting Wei, Weiliang Zhu, Jian Zhang
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 42, Iss 1, Pp 1-19 (2023)
Abstract Background Small cell lung cancer (SCLC) is the most aggressive subtype of lung cancer. Although most patients are initially sensitive to first-line combination chemotherapy with cisplatin and etoposide, chemotherapy drug resistance easily d
Externí odkaz:
https://doaj.org/article/fe2724d2a8544242a651cd9369d3d842
Publikováno v:
Preventive Medicine Reports, Vol 35, Iss , Pp 102304- (2023)
The rate of cannabis use by cancer patients is climbing. However, as the risk of mental illness caused by cannabis use in cancer patients has not been effectively evaluated, this study will analyze the association between cannabis use and depression
Externí odkaz:
https://doaj.org/article/a1dc670c4846477fb8fc5bf94a3017e9
Microsatellite instability states serve as predictive biomarkers for tumors chemotherapy sensitivity
Autor:
Taojun Ye, Anqi Lin, Zhengang Qiu, Shulu Hu, Chaozheng Zhou, Zaoqu Liu, Quan Cheng, Jian Zhang, Peng Luo
Publikováno v:
iScience, Vol 26, Iss 7, Pp 107045- (2023)
Summary: There is an urgent need for markers to predict the efficacy of different chemotherapy drugs. Herein, we examined whether microsatellite instability (MSI) status can predict tumor multidrug sensitivity and explored the underlying mechanisms.
Externí odkaz:
https://doaj.org/article/df47a10b8ecb4920b175bfd5e7e0ee89
Autor:
Jiahao Liu, Yinghao Wen, Zhen Liu, Shu Liu, Ping Xu, Yan Xu, Shuting Deng, Shulu Hu, Rongcheng Luo, Jingwen Jiang, Guifang Yu
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 23, Iss , Pp 324-335 (2021)
VPS33B is reported to be a tumor suppressor in hepatocellular carcinoma, nasopharyngeal carcinoma, colon cancer, and lung adenocarcinoma. Here, we observed that reduced VPS33B protein level was an unfavorable factor that promoted the pathogenesis of
Externí odkaz:
https://doaj.org/article/43a3e7953c984a95b2a18bad1941693d
Autor:
Zhen Liu, Shu Liu, Guifang Yu, Jingwen Jiang, Rongcheng Luo, Shuting Deng, Yinghao Wen, Jiahao Liu, Yan Xu, Shulu Hu, Ping Xu
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 23, Iss, Pp 324-335 (2021)
Molecular Therapy. Nucleic Acids
Molecular Therapy. Nucleic Acids
VPS33B is reported to be a tumor suppressor in hepatocellular carcinoma, nasopharyngeal carcinoma, colon cancer, and lung adenocarcinoma. Here, we observed that reduced VPS33B protein level was an unfavorable factor that promoted the pathogenesis of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc43672a4405a38b548b5bf4827c9af8
http://www.sciencedirect.com/science/article/pii/S2162253120303668
http://www.sciencedirect.com/science/article/pii/S2162253120303668